Literature DB >> 10085334

Nitric oxide mediates the central sensitization of primate spinothalamic tract neurons.

Q Lin1, J Palecek, V Palecková, Y B Peng, J Wu, M Cui, W D Willis.   

Abstract

Nitric oxide (NO) has been proposed to contribute to the development of hyperalgesia by activating the NO/guanosine 3',5'-cyclic monophosphate (cGMP) signal transduction pathway in the spinal cord. We have examined the effects of NO on the responses of primate spinothalamic tract (STT) neurons to peripheral cutaneous stimuli and on the sensitization of STT cells following intradermal injection of capsaicin. The NO level within the spinal dorsal horn was increased by microdialysis of a NO donor, 3-morpholinosydnonimine (SIN-1). SIN-1 enhanced the responses of STT cells to both weak and strong mechanical stimulation of the skin. This effect was preferentially on deep wide dynamic range STT neurons. The responses of none of the neurons tested to noxious heat stimuli were significantly changed when SIN-1 was administered. Intradermal injection of capsaicin increased dramatically the content of NO metabolites, NO-2/NO-3, within the dorsal horn. This effect was attenuated by pretreatment of the spinal cord with a nitric oxide synthase (NOS) inhibitor, NG-nitro-L-arginine methyl ester (L-NAME). Sensitization of STT cells induced by intradermal injection of capsaicin was also prevented by pretreatment of the dorsal horn with the NOS inhibitors, L-NAME or 7-nitroindazole. Blockade of NOS did not significantly affect the responses of STT cells to peripheral stimulation in the absence of capsaicin injection. The data suggest that NO contributes to the development and maintenance of central sensitization of STT cells and the resultant mechanical hyperalgesia and allodynia after peripheral tissue damage or inflammation. NO seems to play little role in signaling peripheral stimuli under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10085334     DOI: 10.1152/jn.1999.81.3.1075

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  13 in total

Review 1.  The role of nitric oxide in nociception.

Authors:  Z D Luo; D Cizkova
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Chemical mediators of migraine: preclinical and clinical observations.

Authors:  Saurabh Gupta; Stephanie J Nahas; B Lee Peterlin
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

Review 3.  Role of nitric oxide in cluster headache.

Authors:  Anna Steinberg; A Ingela M Nilsson Remahl
Journal:  Curr Pain Headache Rep       Date:  2012-04

Review 4.  Emerging targets in migraine.

Authors:  Jan Hoffmann; Peter J Goadsby
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 5.  The role of TRPV1 receptors in pain evoked by noxious thermal and chemical stimuli.

Authors:  William D Willis
Journal:  Exp Brain Res       Date:  2009-03-18       Impact factor: 1.972

Review 6.  Migraine: where and how does the pain originate?

Authors:  Karl Messlinger
Journal:  Exp Brain Res       Date:  2009-03-14       Impact factor: 1.972

7.  Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors.

Authors:  XiChun Zhang; Vanessa Kainz; Jun Zhao; Andrew M Strassman; Dan Levy
Journal:  Ann Neurol       Date:  2013-06-17       Impact factor: 10.422

Review 8.  Central sensitization: a generator of pain hypersensitivity by central neural plasticity.

Authors:  Alban Latremoliere; Clifford J Woolf
Journal:  J Pain       Date:  2009-09       Impact factor: 5.820

9.  Superoxide signaling in pain is independent of nitric oxide signaling.

Authors:  Hee Young Kim; Jigong Wang; Ying Lu; Jin Mo Chung; Kyungsoon Chung
Journal:  Neuroreport       Date:  2009-10-28       Impact factor: 1.837

10.  Changes in synaptic effectiveness of myelinated joint afferents during capsaicin-induced inflammation of the footpad in the anesthetized cat.

Authors:  P Rudomin; E Hernández
Journal:  Exp Brain Res       Date:  2008-02-05       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.